T1	HMM 849 870	overall survival (OS)
T2	HMM 904 913	Median OS
T3	HMM 1083 1129	Median progression-free survival (PFS, months)
T4	HMM 1342 1359	longer OS and PFS
T5	HMM 1578 1588	OS and PFS
T6	HMM 1715 1744	Pemetrexed-cisplatin toxicity
T7	HMM 1885 1893	survival
T8	HMM 2004 2024	OS and PFS advantage
